3 completed, 1 recruiting, 1 terminated, 1 withdrawn. 6 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 3, Recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Asthenia: new trials by email Literature Review of Asthenia trials Research Report on Asthenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TCM Formula vs. HMB in Pre-Frail Elders: Muscle Strength and Bone Status TCM Formula, HMB (beta-Hydroxy-beta-methylbutyrate) - Pre-Frailty, Sarcopenia | Phase 2 | Recruiting | Tri-Service General Hospital (TSGH) | 90 | 2026-04-02 | 2026-05-19 |
| Redefining Survivorship: POWER to Maximize Physical Function for Survivors of Critical Illness Power training - Critical Illness, Muscle Atrophy or Weakness | Phase 1 / Phase 2 | Withdrawn | Kirby Mayer | 2021-12-01 | 2020-10-28 | |
| Evaluation of FDY-5301 in Major Trauma Patients in ICU FDY-5301, Placebo - ICU Acquired Weakness | Phase 2 | Terminated | Faraday Pharmaceuticals, Inc. | 8 | 2021-09-20 | 2023-06-13 |
| Evaluation of Clinical Efficacy and Safety of Nuvastatic in Cancer Asthenia Nuvastatic TM (C5OSEW5050ESA) 1000 mg - Asthenia, Cancer | Phase 2 / Phase 3 | Completed | Natureceuticals Sdn Bhd | 110 | 2017-09-02 | 2020-09-16 |
| Dopamine Agonist for Hemispatial Neglect and Motor Deficit Post Stroke Rotigotine - Right Hemisphere Stroke, Hemispatial Neglect | Phase 2 | Completed | University College, London | 20 | 2010-01-01 | 2011-02-21 |
| Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms Coenzyme Q10, Placebo - Pain, Weakness | Phase 2 / Phase 3 | Completed | Catherine Buettner | 68 | 2009-12-01 | 2017-01-23 |
Muscular Atrophy (3) · Critical Illness (1) · Muscle Cramp (1) · Muscle Weakness (1) · Myalgia (1) · Myositis, Inclusion Body (1) · Neoplasms (1) · Neurologic Manifestations (1) · Osteoporosis (1) · Pain (1) · Perceptual Disorders (1) · Sarcopenia (1) · Stroke (1)
Pathological Conditions, Signs and Symptoms (6) · Signs and Symptoms (6) · Nervous System Diseases (5) · Neurologic Manifestations (4) · Neuromuscular Manifestations (4) · Atrophy (3) · Pathological Conditions, Anatomical (3) · Musculoskeletal Diseases (2) · Pathologic Processes (2) · Bone Diseases (1) · Bone Diseases, Metabolic (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1)
beta-hydroxyisovaleric acid (1) · coenzyme Q10 (1) · rotigotine (1)
Catherine Buettner (1) · Faraday Pharmaceuticals, Inc. (1) · Kirby Mayer (1) · Natureceuticals Sdn Bhd (1) · Tri-Service General Hospital (TSGH) (1) · University College, London (1)
United States (3) · India (1) · Taiwan (1) · United Kingdom (1)
Catherine Buettner, MD, MPH (1) · Ghanashyam Biswas, PHD (1) · Jui-Shan Lin, MD (1) · Kirby P Mayer, DPT (1)
K23AR055664 (1)